Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

计划入组 240 人 · 首次发布于 2024 年 6 月 11 日

Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and Its Relation to Atherosclerosis.

计划入组 140 人 · 首次发布于 2021 年 6 月 23 日

Immunogenicity of SA 14-14-2 JE Vaccine

计划入组 1,000 人 · 首次发布于 2012 年 7 月 10 日

14-3-3 dimer targeting therapeutics

TT-14

Sm-14

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

Augurex Presents Novel 14-3-3eta Biomarker Data for Axial Spondyloarthritis Diagnosis at ACR Convergence 2025

FDA Grants Breakthrough Device Designation to Augurex's SPINEstat Test for Axial Spondyloarthritis Diagnosis

Biological E's 14-Valent Pneumococcal Vaccine Shows Promise in Phase 3 Trial